Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Tekmira Pharmaceuticals Corp announces public offering of shares


Thursday, 13 Mar 2014 07:30am EDT 

Tekmira Pharmaceuticals Corp:Prices an underwritten public offering of 2,125,000 shares at a price of$28.50 per share for aggregate gross proceeds of $60,562,500.Granted underwriters a 30-day option to purchase up to an additional 318,750 shares to cover over-allotments, if any, which would result in additional gross proceeds.Offering is expected to close on or about March 18.Net proceeds will be used to develop and advance product candidates through clinical trials, for working capital and for general corporate purposes. 

Company Quote

20.17
-0.82 -3.91%
21 Oct 2014